Charge-reversible Multi-functional HPMA Copolymers for Mitochondrial Targeting.

Lian Li

DOI: https://doi.org/10.1021/acsami.7b09693

IF: 9.5

2017-01-01

ACS Applied Materials & Interfaces

Abstract:Mitochondrial-oriented delivery of anticancer drugs has been considered as a promising strategy to improve the anti-tumor efficiency of chemotherapeutics. However, the physiological and biological barriers from the injection site to the final mitochondrial action site remain to be great challenges. Herein, a novel mitochondrial-targeted multifunctional nano-complex based on N-(2-hydroxypropyl) methacrylamide (HPMA) copolymers (MPC) is designed to enhance drug accumulation in mitochondria. The MPC possess various functions such as extracellular pH response, superior cellular uptake, lysosome escape and mitochondrial targeting. In detail, the MPC was formed by two oppositely charged HPMA copolymers, i.e., a positively charged mitochondrial targeting guanidine group modified copolymers (P-GPMA-KLA) and a charge reversible 2,3-dimethylmaleicanhydride (DMA) modified copolymers (P-DMA). The MPC could remain stable in the circulation (pH7.4) but be cleaved to expose the positive charge of guanidine group immediately in response to the mild acidity of tumor tissues (pH 6.5). The gradually exposure of positive charged guanidine will simultaneously facilitate the endocytosis, endo/lysosome escape and mitochondrial targeting. The in vitro experiments showed that compared with copolymers without guanidine modification, the cellular uptake and mitochondrial targeting ability of MPC in simulated tumor environment (MPC@pH6.5) separately increased 4.3 folds and 23.8 folds. The in vivo experiments were processed on B16F10 tumor-bearing C57 mice and the MPC showed the highest accumulation in the tumor site and a peak tumor inhibition rate of 82.9%. In conclusion, multi-functional mitochondrial targeting HPMA copolymers provide a novel and versatile approach for cancer therapy.